๐ฌDeep Research
SBRA โ Sabra Health Care REIT ยท catalysts, narrative & risks
Sabra Health Care REIT (SBRA) โ Analysis as of 2026-10-27
Recent Catalysts (last ~1โ3 months)
July 21, 2026 โ Business update with raised guidance. Sabra issued a business update and increased its full-year 2026 guidance, including normalized FFO of $1.53โ$1.55 and normalized AFFO of $1.59โ$1.61 per diluted share, representing +7% and +8% growth, respectively, over 2025 [3]. Management attributed much of the upside to portfolio quality improvements, including rent resets and lease amendments that collectively add over $9 million per year in cash NOI run-rate [3].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ